The aims of this study were to establish whether glibenclamide prevents the isoflurane-induced cardioprotection in diabetic patients undergoing coronary surgery ( CABG ) and whether this cardioprotective effect can be restored by preoperative shift from glibenclamide to insulin therapy .
